Keywords: Pfizer, Fourth quarter and full year 2010 results, Share buyback, R&D job cutsm UK, USA

Pfizer’s 4th-quarter 2010 results beat expectations but guidance disappoints; $5 billion share buyback

Article | 02 February 2011

 Along with presenting fourth-quarter and full year 2010 financial results yesterday, US drug behemoth Pfizer (NYSE: PFE) revealed a share buyback ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Pfizer

Go to company listing